PREPARATION PACK 2026 KEY CONCEPTS
AND REVISION NOTES
◉ Low Intensity Statin. Answer: Lowers LDL-C by </=30%
Pravastatin 10-20 mg
Lovastatin 20 mg
◉ Cervical Cancer Screening. Answer: Women 21-65 Pap smear with
cytology Q3 years
Women 30-65 Pap smear with HPV testing Q5 years
◉ Cervical Cancer Screening Exemptions. Answer: Women >65 years
with previously normal screenings
Women who had a hysterectomy with removal of the cervix and no
history of precancerous lesion
◉ High Grade Intraepithelial Lesion Treatments. Answer:
Cryotherapy, laser therapy, loop excision and cold knife excision
,◉ Early Stage Cervical Cancer Treatment. Answer: Surgery or
chemoradiation
◉ Ottawa Rules for Ankle. Answer: XR required if 1/3:
Tenderness at posterior edge of lateral malleolus
Tenderness at posterior edge of medial malleolus
Inability to bear weight both immediately after injury or in the ED
◉ Ottawa Rules for Foot. Answer: XR required if 1/3:
Tenderness at base of 5th metatarsal
Tenderness at navicular
Inability to bear weight both immediately after injury or in the ED
◉ Exceptions to the Ottawa Rules. Answer:
Inebriation/uncooperative patient
Other distracting painful injuries that cloud the perception of pain in
the regions listed in rules
Diminished sensation in legs
Gross swelling which prevents palpating of medial malleolus
***Patient is under 18 years old****
◉ Ottawa Rules for Knee. Answer: Age >55
,Isolated tenderness of patella
Tenderness at head of fibula
Inability to flex 90 degrees
Inability to bear weight both immediately and in the ED
◉ Chlamydia and Gonorrhea Screening for Women. Answer: Women
<24 who are sexually active
Women >24 with risk factors identified
◉ Risk Factors for Gonorrhea/Chlamydial Infection in Women.
Answer: Age 20-24
New sex partner
More than 1 sex partner
Sex partner with concurrent sex partners
Sex partner with an STI
Inconsistent condom usage
Previous or coexisting STI
Exchange of sex for money or drugs
Incarceration
Military recruits
Black and Hispanic
, ◉ Screening Test for Gonorrhea/Chlamydia. Answer: Nucleic Acid
Amplification Test (NAAT)
◉ Screening for Chronic Kidney Disease. Answer: USPSTF has
insufficient information to recommend screening for CKD in
asymptomatic adults
◉ Screening for COPD. Answer: The USPSTF DOES NOT recommend
screening for COPD in asymptomatic adults using spirometry
◉ Diagnosis of COPD. Answer: FEV1:FVC ratio of <70% with less
than 12% reversibility
◉ Colorectal Cancer Screening. Answer: Start screening at 50 years
and continue until the age of 75 years
◉ Screening Tests for Colorectal Cancer. Answer: Fecal Occult Blood
Testing (annually)
Sigmoidoscopy (Q5 years)
Screening Colonoscopy (Q10 years)
◉ Screening for Colon Cancer in Adults >75 years. Answer: 76-85:
recommendation against screening unless patient has risk factors
>85: do not screen as there is no net benefit